Mukka Proteins IPO: A Look at the Leading Fish Protein Player

Mukka Proteins Ltd. (MPL), a leading player in the Indian fish protein industry, is set to launch its initial public offering (IPO). This analysis dives into the company’s details, financials, and investment potential.

About the Company

  • Established player with a 25-30% market share in the domestic fish meal and fish oil industry.
  • Consistently awarded by MPEDA for export performance.
  • Operates across India and Oman with strategically located facilities for efficient raw material access.
  • First mover in the Ento Protein segment with high global demand and margin potential.

IPO Details

  • Issue size: ₹224 crore
  • Price band: ₹26 – ₹28 per share
  • Issue dates: February 29 – March 4, 2024
  • Listing: BSE and NSE

Read more: 5 Top Penny Stocks in the United States (2024)


  • Demonstrates consistent revenue and net profit growth over the past three years.
  • FY24 H1 financials indicate continued growth trajectory.
  • P/E ratio based on FY24 annualized earnings appears reasonable (subject to final calculation).
Mukka Proteins Ltd. (MPL)
Mukka Proteins Ltd. (MPL)

Investment Strategy

  • MPL’s strong market position, growth prospects, and entry into the high-demand Ento Protein segment make it an attractive investment opportunity.
  • Investors with a medium to long-term horizon and no reservations about the industry can consider subscribing to the IPO.

Mukka Proteins IPO FAQs

1. Why Invest in the Mukka Proteins IPO?

The Mukka Proteins IPO allows you to invest in the company before its shares are publicly traded on the stock exchange. This offers a potential for gains from the listing price if the stock price increases after listing. You can invest for short-term listing gains or for the long term based on your investment goals.

2. How is the Mukka Proteins IPO Looking?

Analyst recommendations for the IPO are generally positive, with terms like “Apply” being used by BP Equities and Dilip Davda.

3. What Should Investors Do?

Analyst reports and recommendations suggest subscribing to the IPO. You can find these reports from leading stockbrokers to help you make an informed decision.

4. Is the Mukka Proteins IPO Good?

Based on available information, subscribing to the IPO is recommended.

5. Is the Mukka Proteins IPO Worth Investing In?

Analyst Dilip Davda suggests subscribing to the IPO. However, remember to conduct your own research before making any investment decisions.

6. When Will I Know My Allotment Status?

The allotment status for the Mukka Proteins IPO is expected to be available around March 5, 2024. Allotted shares will be credited to your Demat account by March 6, 2024. You can check the allotment status using the provided link (link not provided due to policy).

7. When Will the Mukka Proteins IPO List?

The official listing date is not yet confirmed, but the tentative listing date on both BSE and NSE is March 7, 2024.


This analysis is for informational purposes only and should not be considered financial advice. Please consult a qualified financial advisor before making any investment decisions.

Additional Notes

  • The comparison with listed peers provided in the offer document might not be entirely accurate due to differing business models.
  • The company has not declared any dividends in the past.